Literature DB >> 15208512

Leptin functioning in eating disorders.

Palmiero Monteleone1, Antonio DiLieto, Eloisa Castaldo, Mario Maj.   

Abstract

Leptin is an adipocyte-derived hormone, which is involved predominantly in the long-term regulation of body weight and energy balance by acting as a hunger suppressant signal to the brain. Leptin is also involved in the modulation of reproduction, immune function, physical activity, and some endogenous endocrine axes. Since anorexia nervosa (AN) and bulimia nervosa (BN) are characterized by abnormal eating behaviors, dysregulation of endogenous endocrine axes, alterations of reproductive and immune functions, and increased physical activity, extensive research has been carried out in the last decade in order to ascertain a role of this hormone in the pathophysiology of these syndromes. In this article, we review the available data on leptin physiology in patients with eating disorders. These data support the idea that leptin is not directly involved in the etiology of AN or BN. However, malnutrition-induced alterations in its physiology may contribute to the genesis and/or the maintenance of some clinical manifestations of AN and BN and may have an impact on the prognosis of AN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208512     DOI: 10.1017/s1092852900009615

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  11 in total

1.  The multimodal treatment of eating disorders.

Authors:  Katherine A Halmi
Journal:  World Psychiatry       Date:  2005-06       Impact factor: 49.548

Review 2.  Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?

Authors:  Jörg Dötsch; Kai Nüsken; Michael Schroth; Wolfgang Rascher; Udo Meissner
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

Review 3.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

4.  Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities.

Authors:  F Jacoangeli; S Masala; F Staar Mezzasalma; R Fiori; A Martinetti; C Ficoneri; B Novi; S Pierangeli; G Marchetti; G Simonetti; M R Bollea
Journal:  Eat Weight Disord       Date:  2006-03       Impact factor: 4.652

5.  The relation of weight suppression and body mass index to symptomatology and treatment response in anorexia nervosa.

Authors:  Laura A Berner; Jena A Shaw; Ashley A Witt; Michael R Lowe
Journal:  J Abnorm Psychol       Date:  2013-08

Review 6.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

7.  Psychobiology of purging disorder: reduction in circulating leptin levels in purging disorder in comparison with controls.

Authors:  David C Jimerson; Barbara E Wolfe; Devon P Carroll; Pamela K Keel
Journal:  Int J Eat Disord       Date:  2010-11-01       Impact factor: 4.861

8.  Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Authors:  Eva M Marco; María S García-Gutiérrez; Francisco-Javier Bermúdez-Silva; Fabricio A Moreira; Francisco Guimarães; Jorge Manzanares; María-Paz Viveros
Journal:  Front Behav Neurosci       Date:  2011-10-05       Impact factor: 3.558

9.  Leptin in pediatrics: A hormone from adipocyte that wheels several functions in children.

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed Kassem
Journal:  Indian J Endocrinol Metab       Date:  2012-12

Review 10.  The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.

Authors:  Maria-Paz Viveros; Francisco-Javier Bermúdez-Silva; Ana-Belén Lopez-Rodriguez; Edward J Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.